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Background and method: This meta-analysis sought to: quantify the effects of isometric resistance 
training (IRT) on the magnitude of change in systolic blood pressure (SBP), diastolic blood pressure 
(DBP), mean arterial pressure (MAP) and resting heart rate in adults; and examine whether the 
magnitude of change in SBP, DBP, MAP and heart rate was different with respect to the patient 
demographic characteristics and IRT parameters. To be included in the meta-analysis, studies had to 
be randomized controlled trials lasting 2 or more weeks, investigating the effects of IRT on blood 
pressure in adults. The methodological quality of the studies selected was evaluated using the PEDro 
scale. For each main outcome measure, an average effect size and its respective 95% confidence 
intervals were calculated.  
Results: A total of 16 articles (492 participants) fulfilled the selection criteria (mean quality score in 
the PEDro scale of 5.9). Compared with control groups, IRT groups showed statistically significant 
(P<0.05) and clinically relevant (>2mmHg) positive effects on the SBP (-5.23mmHg) and MAP (-
2.9mmHg). IRT groups also showed statistically significant, but not clinically relevant reduction in 
DBP (-1.64mmHg). Furthermore, IRT groups did not report any statistically significant and clinically 
relevant (>5bpm) effect on resting heart rate (-0.08bpm).  
Conclusion: The analysis of moderator variables showed that none of them exhibited a statistically 
significant relationship with the positive effects of IRT for lowering blood pressure. Therefore, IRT 
may be considered an appropriate nonpharmacologic treatment for lowering SBP and MAP.  
Keywords: adults, blood pressure, hypertension, isometric exercise training, treatment 
Abbreviations: AHA, American Heart Association; bj, regression coefficient for the predictor variable; 
BP, blood pressure; CI, confidence interval; D+, effect size; DBP, diastolic blood pressure; DRT, 
dynamic resistance training; ICC, intra-class correlation coefficient; IRT, isometric resistance training; 
k, number of studies; MAP, mean arterial pressure; MVC, maximal voluntary contraction; QE, statistic 
for testing the model misspecification; QR, statistic for testing the statistical significance of the 
predictor variable; R2, proportion of variance explained by the predictor variable; RCTs, randomized 
control trials; SBP, systolic blood pressure; SDC, supplemental digital content; SD, standard 
deviation; SE, standard error
INTRODUCTION  
Increasing levels of physical activity has been recommended as a nonpharmacological therapy, as 
part of a global lifestyle modification strategy, for populations at high risk of developing 
hypertension and those with controlled hypertension [1,2]. Thus, the general health 
recommendation (class I, level B evidence) for lowering blood pressure (BP) is to perform moderate 
to high-intensity physical activity for at least 30min on most days per week and to achieve a total of 
at least 150min per week [2,3]. At present, and based on their documented efficacy in lowering BP, 
aerobic training (e.g. speed walking, jogging, dancing, cycling, swimming, etc.) and/or dynamic 
resistance training (DRT) (i.e. weight lifting and circuit training) have been considered the gold-
standard methodologies for increasing levels of physical activity. It has been reported that aerobic 
training causes reductions in systolic BP (SBP) and diastolic BP (DBP) of about 3–6mmHg, whereas 
DRT can reduce resting SBP by 2–3mmHg [2,4–9].  
Adherence to aerobic training and DRT has, however, not always been optimum as some patients 
are unwilling or unable to adopt the aforementioned lifestyle changes [10]. In this sense, both 
training modalities commonly require access to a fitness centre or suitable equipment. Furthermore, 
most individuals with hypertension or at high risk of developing hypertension (approximately two 
out of every three cases) present associated comorbidities (i.e. obesity, arthritis, diabetes, lung 
disease, etc.) and have a low level of physical fitness (<20th percentile) [11]. Consequently, for these 
patients, it would be advisable that the aerobic training and DRT sessions were designed by a 
certified professional (i.e. personal trainer) that takes their individual characteristics and limitations 
into account. As these two constraints imply an economic cost, the individual may choose to avoid 
these types of interventions.  
Literature review [4] and meta-analyses [12–14] have indicated that low to moderate intensity 
isometric resistance training (IRT) (i.e. exercises that involve static contraction of muscles without 
joint movement such as isometric handgrip contractions) might be a useful non-pharmacological 
therapy for the prevention and management of hypertension, at least during early stages where 
dropping out rates are usually high. This statement has been based on the following four main 
points: their great efficacy for lowering resting SBP (~5mmHg) and DBP (~4mmHg); the relatively 
inexpensive equipment needed (e.g. a handgrip device) that allows to perform the exercises 
anywhere; the lower level of cardiovascular stress elicited; and it is less time-consuming than other 
training methodologies (each IRT session lasts 8–12min approximately).  
Despite recent meta-analyses by Carlson et al. [13] and Inder et al. [14] on the topic of the efficacy of 
IRT for BP management, there has been a rapid increase in publication of isometric resistance 
training trials over the past 3 years that necessitates an update. Furthermore, the application of 
more robust statistical methods to analyse the data available might contribute to establish more 
accurate estimations of the true effects of IRT on the main BP outcomes. As an example, the use of 
less demanding cut-off scores for the I2 index (e.g. >50%) when justifying the selection of random 
effects models to calculate the effect sizes and their confidence intervals (CIs) may allow a better 
management of the within-study and between-studies variances (i.e. heterogeneity) [15]. 
Furthermore, the implementation of the trim-and-fill method provides quantitative and powerful 
statistics for assessing the possible existence of publication bias as it does not require the subjective 
interpretation of the funnel plot and it also provides an adjustment of the effect sizes if it is needed. 
Finally, the application of regression-based techniques (meta-regressions) has been suggested as a 
more effective approach for adjusting the influence of continuous moderators (e.g. age, length of 
the intervention program, dose or intensity of the intervention) on the effect sizes in contrast to the 
standard meta-analytic techniques that usually require dichotomization using arbitrary cut-off 
scores.  
Therefore, the main purposes of the current study were as follows: to conduct a meta-analysis 
quantifying the effects of IRT on the magnitude of change in SBP, DBP, mean arterial pressure (MAP) 
and resting heart rate in adults; to examine whether the magnitude of change in SBP, DBP, MAP and 
heart rate was different with respect to the patient demographic characteristics (age, sex, BP status) 
and IRT parameters (length of the program, extremity used for carrying out the exercises, type of 
exercises, intensity). 
METHOD 
To accomplish our objectives, a systematic review and a meta-analysis were carried out in 
accordance with the recommendations and criteria outlined in the Preferred Reporting Items for 
Systematic Reviews and Meta-analysis (PRISMA) statement [16]. 
Study selection  
To be included in the meta-analysis, the studies had to fulfil the following criteria: the study had to 
be a randomized controlled trial (RCT), lasting 2 or more weeks, which analysed the effects of IRT; 
the participants in the study had to be adults (aged ≥18 years); the minimum sample size in the post-
test had to be of five participants per group; the study had to report enough statistical data to 
calculate the effect sizes; the study had to be published or carried out before January 2018; and the 
study could be written in English or Spanish. Animal studies, review articles, acute exercise studies 
and non-RCTs were excluded. 
Search strategy  
Potential studies were identified by combined search processes, clearly planned and ordered. Firstly, 
the following electronic databases were consulted: PubMed, Scopus and the Cochrane Library with 
the following search terms included in Boolean search strategies: (’hypertension’ OR ‘hypertensive’ 
OR ‘normotensive’ OR ‘normotension’) AND blood pressure AND (’isometric exercise’ OR ‘isometric 
physical activity’ OR ‘isometric physical exercise’ OR ‘isometric strength’). By using filter criteria of 
the respective databases, the search was limited to publication dates (to 12/31/2017), human 
species, ages (adult: 18þyears), and English and Spanish languages. Secondly, several specialized 
electronic journals were also consulted, including: Journal of Hypertension, Mayo Foundation for 
Medical Education and Research, Hypertension Research Journal and The Japanese Society of 
Hypertension. Finally, the reference lists of the studies recovered were also consulted. Two 
reviewers independently: a) screened the title and abstract of each reference to locate potentially 
relevant studies and, once full-text of the screened documents were obtained, b) reviewed them in 
detail to identify articles that met the selection criteria. A third external reviewer was consulted to 
resolve discrepancies. 
Data extraction and quality assessment  
With the aim of guaranteeing the maximum objectivity possible, a codebook was produced that 
specified the standards followed in coding each of the characteristics of the studies. The moderator 
variables of the studies selected were coded and grouped into three categories according to Lipsey 
[17] recommendations: substantive (participants, context and treatment), methodological and 
extrinsic variables. SDC 1 (http://links.lww.com/HJH/B50) displays a brief description of the 
moderator variables coded separately by category.  
The outcome measures were SBP, DBP, MAP (which was calculated following the method described 
in Inder et al. [14]) and heart rate.  
The methodological quality of the studies selected was evaluated using the Physiotherapy Evidence 
Database Scale (PEDro) [18]. The PEDro scale has demonstrated being reliable in clinical and 
randomized trials [19,20], and has been used in several intervention meta-analyses [13,21,22]. A 
total score out of 10 is derived for each study, adding the criteria that are satisfied. A PEDro score 
ranging from 6 to 10 is indicative of high quality, whereas scores of 4–5 indicate fair quality and 
scores 3 or less indicate poor quality [23].  
To assess the inter-coder reliability of the coding process, two researchers coded all the selected 
studies (including methodological quality assessment). For the quantitative moderator variables, 
intra-class correlation coefficients (ICCs) were calculated, whereas for the qualitative moderator 
variables, Cohen’s kappa coefficients were applied. On average, the ICC was 0.994 (range 0.98–1.0) 
and the kappa coefficient was 0.989 (range 0.77–1.0), which can be considered highly satisfactory, as 
proposed by Orwin and Vevea [24]. The inconsistencies between the two coders were resolved by 
consensus or by consulting with athird reviewer. When the inconsistencies were due to ambiguity in 
the coding book, this was corrected. The codebook can be obtained from the corresponding author 
upon request. 
Statistical analysis  
All outcomes were reported as means and standard deviations (SDs). For each of the four outcome 
measures (SBP, DBP, MAP and heart rate), an effect size was calculated as the average difference 
between the post-test and pretest change scores of the experimental and control groups: 𝐷 =
(𝑚𝑃𝑜𝑠𝑡
𝐸 − 𝑚𝑃𝑟𝑒
𝐸 ) − (𝑚𝑃𝑜𝑠𝑡
𝐶 − 𝑚𝑃𝑟𝑒
𝐶 ) [25]. Negative D values indicated a better result for the IRT 
group than for the control one. For the assessment of the reliability of the effect size calculations, 
the same random sample of studies used in the coding reliability study was subjected to a double 
process of effect size calculations, obtaining excellent intercoder reliability, with intra-class 
correlations of over 0.90.  
Separate meta-analyses were performed for each outcome measure. For each one of them, an 
average effect size (D+) and a 95% CI was calculated by assuming a random effects model, with the 
inverse variance as the weighting factor [26]. Heterogeneity of the effect sizes across studies was 
assessed by means of Cochrane Q statistic and the I2 index. A forest plot was also constructed for 
each meta-analysis. Lack of homogeneity was considered for Cochrane Q tests with P < 0.10 and/or 
for I2 indices at least 50%. Funnel plots were constructed and the trim-and-fill method [27] was 
applied to assess whether publication bias might be a threat to the validity of the meta-analytic 
results.  
Magnitude-based inferences about the true IRT net effects on each main outcome measure (i.e. SBP, 
DBP, MAP and heart rate) were estimated by expressing the probabilities that the true value of the 
meta-analysed effect was trivial, beneficial or harmful in relation to predetermined threshold values 
for benefit and harm (i.e. smallest worthwhile clinical changes). Probabilities were then used to 
make a qualitative probabilistic inference about the effects [28].  
Clinical [29,30] and observational [31] studies have suggested that a reduction of BP by 1–3mmHg 
could have a substantial impact on cardiovascular disease incidence. For example, Hardy et al. [30] 
reported that a 1mmHg population-wide SBP reduction was associated with 20.3 and 13.3 fewer 
heart failure events per 100000 person-years in African Americans and whites, respectively. Thus, 
and giving their clinical implications, a reduction of 2mmHg (an intermediate value between 1 and 
3mmHg) were considered the smallest substantial changes for BP outcomes (SBP, DBP and MAP). 
Although elevated heart rate values are associated with an increased risk for cardiovascular disease 
[32,33], the impact of specific reductions in this variable on the likelihood of sustaining a 
cardiovascular disease has not been estimated yet (from the authors’ knowledge). Consequently, in 
the absence of robust anchors for the smallest worthwhile clinical reductions for heart rate, our 
inferences were based on the results reported by Paul et al. [34] that showed that an increase in 
heart rate of above 5bpm over time was associated with mortality in hypertensive patients. An 
effect was deemed unclear if its CI overlapped the thresholds for substantiveness, that is, if the 
effect could be substantial in both a positive and negative sense. Otherwise, the effect was clear and 
deemed to have the magnitude of the largest observed likelihood value. This was qualified with a 
probabilistic term using the following scale: less than 0.5%, most unlikely;0.5–
5%,veryunlikely;morethan5–25%,unlikely; more than 25–75%, possible; more than 75–95%, likely; 
more than 95–99.5%, very likely; and more than 99.5%, most likely [35]. The present study 
considered a ‘substantial’ main effect when a change was noted in BP outcomes and heart rate that 
had reported a probability of the worthwhile differences of ‘likely’ or higher (>75% positive or 
negative).  
The influence of qualitative moderator variables [i.e. sex (male, female, mixed), clinical status 
(normotensive vs. hypertensive), extremity used for carrying out the exercises (upper vs. lower) and 
type of exercise (unilateral vs. bilateral)] on the effect sizes was performed by means of analyses of 
variance (ANOVAs) and assuming a mixed-effects model. To make direct comparisons with the 
analysis of moderator results reported by Inder et al. [14], the continuous variables of weeks of 
interventions and age were also dichotomized using the same cut-off scores. Mixed-effects meta-
regressions were also applied to test the influence of continuous moderators on the effect sizes, 
such as the PEDro score, number of weeks of intervention, intensity of the intervention, average  
percentage of males in the two groups, difference between the male percentages in the two groups, 
average age of the two groups and mean difference between the age of the two groups. QB and Qw 
for ANOVAs, and QR and QE statistics for meta-regressions were calculated to test the statistical 
significance of each moderator variable and to assess the model misspecification, respectively. In 
addition, an estimate of the proportion of variance accounted for by the moderator was calculated 
by means of R2 = 1 – Ƭ2RES/Ƭ2TOTAL, with Ƭ2RES and Ƭ2TOTAL being the residual and total heterogeneity 
variance estimates, respectively [36]. Calculations for the intra-group inferences were made with the 
spreadsheet designed by Hopkins [28]. The forest plots were carried out with the Review Manager 
(RevMan) software package (version 5.3 for OSX, The Nordic Cochrane Centre, The Cochrane 
Collaboration, 2014, Copenhagen, Denmark). The funnel plots with the trim-and-fill method and the 
ANOVAs and meta-regressions were obtained from the package Comprehensive Meta-analysis 3.3 
[37]. The PRISMA checklist [38] was used to check the reporting quality of the meta-analysis. 
RESULTS  
Study selection  
A total of 893 references were identified with all search strategies, from which 312 were excluded in 
the first screening as duplicates (approximately35%). Four hundred and sixty-eight studies 
(approximately 52%) were eliminated after reading the title and abstract. Another 14 studies did not 
apply isometric exercises (about 2%), 71 did not methodologically comply with the established 
criteria (close to 8%) and 2 other studies were excluded because of data duplication. 
The searching process enabled us to identify 16 articles (21 intervention groups as five studies had 
more than one intervention group, and 17 control groups as one study had two control groups) that 
met the selection criteria [39–54]. Figure 1 shows the flow chart of the selection process of the 
studies. 
 
 
Figure 1 Flow chart of the selection of studies for the meta-analysis. 
 
Descriptive characteristics of the studies  
The main characteristics of each of the integrated studies are present in Table 1. The studies 
selected were carried out between 1992 and 2017. Five studies were carried out in Canada, six in the 
United Kingdom, three in the United States of America, one in Australia and one in Germany. The 
total sample size was of 492 participants, 266 pertaining to the treatment groups and 226 to the 
control groups. In relation to the clinical status of the participants, seven studies were carried out 
with pre or hypertensive participants and nine studies were performed with normotensive 
participants. Five trials included only men, one study was restricted to women only, whereas eight 
trials included both men and women. Two studies did not inform about the sex of the participants. 
The mean age of participants in the samples was 40.4 ± 5.2 years, and the mean percentage of men 
was 60% approximately.  
 
Table 1 Characteristics of the studies included in the meta-analysis 
Reference 
Country Participants 
Length 
(weeks) 
Frequency 
(days/week) Exercise training characteristic Outcome 
Badrov et al. 
(2013b) [39], 
Canada 
CG: 9 F 
EG 1: 12 F 
EG 2: 11 F 
Normotensive 
8 EG1: 3d 
EG2: 5d 
4 x 2 min non-dominant 
isometric handgrip contractions 
at 30% MVC, separated by 4 min 
of rest. 
Significant reductions in SBP 
were observed in both EGs (6 
mmHg) compared to control 
group. 
Badrov et al. 
(2013a) [40], 
Canada 
CG: 7 M and 5 F 
EG: 6 M and 6 F 
Hypertensive 
10 3 4 x 2 min bilateral isometric 
handgrip contractions at 30% 
MVC, separated by 4 min of 
rest. 
The EG obtained a significant 
reduction in resting SBP (8 
mmHg), DBP (5 mmHg), and 
MAP (6 mmHg). 
Baross et al. 
(2012) [41], 
United Kingdom 
CG: 10 M 
EG 1: 10 M 
EG 2: 10 M 
Pre-hypertensive 
patients 
8 3 EG1: 4 x 2 min bilateral leg 
extension isometric contractions 
at 14% MVC, separated by 2 min 
of rest. 
EG2: 4 x 2 min bilateral leg 
extension isometric contractions 
at 8% MVC, separated by 2 min 
of rest. 
Only significant reductions 
were observed in high intensity 
EG1 in SBP (10.8 mmHg), MAP 
(4.7 mmHg) and HR (4.8 BPM). 
Baross et al. 
(2013) [54], 
United Kingdom 
CG: 10 M 
EG: 10 M 
Pre-hypertensive 
patients 
8 3 4 x 2 min bilateral leg extension 
isometric contractions at 85% 
HR, separated by 2 min of rest. 
The EG obtained a significant 
reduction in resting SBP (11 
mmHg) and MAP (5 mmHg). 
Carlson et al. 
(2016) [42], 
Australia 
CG: 8 M and 12 F 
EG: 6 M and 12 F 
Pre-hypertensives 
8 3 EG: 4 x 2 min nondominant 
isometric handgrip contractions 
at 30% MVC, separated by 3 min 
of rest. 
CG: 4 x 2 min non-dominant 
isometric handgrip contractions 
at 5% MVC, separated by 3 min 
of rest. 
The EG obtained a significant 
reduction in SBP (7 mmHg) and 
MAP (4 mmHg). No changes in 
DBP and HR in any group. 
Devereux et al 
(2011) [43], 
United Kingdom 
CG: 13 M 
EG: 13 M 
Normotensive 
patients 
4 3 4 x 2 min bilateral leg extension 
isometric contractions at 95% 
HR, separated by 3 min of rest. 
The EG obtained a significant 
reduction in resting SBP (4.9 
mmHg), DBP (2.8 mmHg) and 
MAP (2.6 mmHg) compared 
with CG. 
Gill et al. (2015) 
[44], United 
States of America 
CG: 4 M and 14 F 
EG1: 4 M and 4 F 
EG2: 2 M and 7 F 
Normotensive 
patients 
3 3 EG1: 4 x 2 min bilateral leg 
extension isometric contractions 
at 23% MVC, separated by 3 min 
of rest. 
EG2: 4 x 2 min bilateral leg 
extension isometric contractions 
The EG2 showed significant 
reductions in SBP (3.6 mmHg), 
DBP (4 mmHg) and MAP (3.9 
mmHg) compared to EG1 and 
CG. Neither EG1 nor CG 
showed changes in any 
variable. 
at 34% MVC, separated by 3 min 
of rest. 
Howden et al. 
(2002) [45], 
United Kingdom 
CG1: 6 M and 2 F 
CG1: 5 M and 3 F 
EG1: 7 M and 2 F 
EG2: 6 M and 2 F 
Normotensive 
patients 
5 3 EG1: 4 x 2 min bilateral leg 
extension isometric contractions 
at 20% MVC, separated by 3 min 
of rest. 
EG2: 4 x 2 min bilateral arm 
flexion isometric contractions at 
30% MVC, separated by 3 min of 
rest. 
Resting SBP was significantly 
reduced after both leg (10 
mmHg) and arm (12.4 mmHg) 
isometric exercise training, 
compared to controls. Resting 
DBP did not change in any 
group. 
Millar et al. 
(2008) [46], 
Canada 
CG: 7 M and 17 F 
EG: 14 M and 11 F 
Normotensive 
patients 
8 3 4 x 2 min alternating bilateral 
isometric handgrip contractions 
at 35% MVC, separated by 1 min 
of rest. 
The EG demonstrated 
significant reductions in resting 
SBP (10 mmHg) and DBP (3 
mmHg). 
Pagonas et al. 
(2017) [47], 
Germany 
CG: 10 M and 13 F 
EG: 9 M and 15 F 
Hypertensive 
patients 
12 5 EG: 2 x 2 min alternating 
bilateral isometric handgrip 
contractions at 30% MVC, 
separated by 1 min of rest. 
CG: 2 x 2 min alternating 
bilateral isometric handgrip 
contractions at 5% MVC, 
separated by 1 min of rest. 
Isometric handgrip training did 
not reduce blood pressure in 
hypertensive patients. 
Ray and Carrasco 
(2000) [48], 
United States of 
America 
CG: 8 
EG: 9 
Normotensive 
patients 
5 4 4 x 3 min dominant isometric 
handgrip contractions at 30% 
MVC, separated by 5 min of 
rest. 
In the trained group, resting 
DBP and MAP significantly 
decreased (5 and 4 mmHg, 
respectively), whereas SBP and 
HR did not significantly change. 
Stiller-Moldovan 
et al. (2012) [49], 
Canada 
CG: 6 M and 3 F 
EG: 7 M and 4 F 
Hypertensive 
patients 
8 3 4 x 2 min alternating bilateral 
isometric handgrip contractions 
at 30% MVC, separated by 1 min 
of rest. 
No significant changes in 
resting SBP, DBP, or HR were 
observed in either the EG or in 
the CG. 
Taylor et al. 
(2003) [50], 
Canada 
CG: 5 M and 3 F 
EG: 5 M and 4 F 
Hypertensive 
patients 
10 3 4 x 2 min alternating bilateral 
isometric handgrip contractions 
at 30% MVC, separated by 1 min 
of rest. 
The EG obtained a significant 
reduction in SBP (10 mmHg) 
and MAP (11 mmHg). No 
changes in DBP and HR. 
Wiles et al. (2010) 
[51], United 
Kingdom 
CG: 11 M 
EG1: 11 M 
EG2: 11 M 
Normotensive 
patients 
8 3 EG1: 4 x 2 min bilateral 
isometric contractions at 21% 
MVC, separated by 2 min of 
rest. 
EG2: 4 x 2 min bilateral 
isometric contractions at 10% 
MVC, separated by 2 min of 
rest. 
SBP, DBP and MAP were 
reduced significantly in EGs 
after training (5.2, 2.6, and 2.5 
mmHg; 3.7, 2.5 and 2.6 mmHg, 
respectively). 
Wiles et al (2017) 
[52], United 
Kingdom 
CG: 28 M 
EG: 28 M 
Normotensive 
patients 
4 3 4 x 2 min bilateral leg extension 
isometric contractions at 95% 
HR, separated by 2 min of rest. 
Significant reductions in resting 
BP (4 mmHg), DBP (3 mmHg), 
and MAP (3 mmHg) compared 
to the control condition. 
Wiley et al (1992) 
[53], United 
States of America 
CG: 8 
EG: 7 
Normotensive 
patients 
8 3 EG: 4 x 2 min dominant 
isometric handgrip contractions 
at 30% MVC, separated by 3 min 
of rest. 
The EG reduced significantly 
SBP (12.7 mmHg) and DBP 
(14.9 mmHg).  
CG, control group; DBP, diastolic blood pressure; EG, experimental group; F, female; HR, heart rate; M, male; MAP, mean 
arterial pressure; MVC, maximal voluntary contraction; SBP, systolic blood pressure. 
 
Collectively, the length of the IRT programmes ranged from 3 to 12 weeks. The study training 
sessions per week ranged from three to five, and intensity ranged from 5 to 35% of one-repetition 
maximum. Nine studies used upper-extremity exercises (handgrip) and seven studies used lower-
extremity exercises (leg press, squats). 
Quality of the selected studies  
The quality scores of each study are displayed in SDC 2 (http://links.lww.com/HJH/B50).The mean 
score obtained with the quality scale (range 0–10) was 5.9 (minimum 4, maximum 8) (higher score 
indicates better quality). Ten (62.5%) studies clearly stated eligibility criteria, all studies were 
randomized and 14 (87.5%) studies matched intervention groups at baseline for BP, although groups 
were also well matched for age and sex. Blinding of outcome assessment was performed in one 
study, but neither of the studies selected specifically reported that the observers were blinded to 
treatment allocation. However, 14 (87.5%) studies clearly reported that more than 85% of 
participants had complied with the intervention, and all studies completed an intent-to-treat 
analysis, between-group analyses and provided point estimates for effect size. 
Effect sizes 
Primary outcomes  
Figures 2–5 show the main results and forest plots for each of the four meta-analyses carried out. 
Compared with control groups, experimental (IRT interventions) groups showed most likely (>99% of 
probability) and likely (>75 – 95% of probability) positive effects on SBP [D+ = -6.00mmHg (95% CI      
-7.75 to -4.26); see Fig. 2], DBP [D+ =  -2.75mmHg (95% CI -3.78 to -1.72); see Fig. 3] and MAP [D+ =    
-3.20mmHg (95% CI -4.69 to -1.71); see Fig. 4]. However, no main effects (>75–95% of probability) 
were observed between controls versus experimental groups for heart rate [D+ = -0.75bpm (95% CI   
-1.83 to 0.34); see Fig. 5]. In the four meta-analyses, the effect sizes exhibited a large heterogeneity 
(based on the Q statistics and the I2 indices; see Figs. 2–5), supporting our decision of applying 
random-effects models. 
Analysis of moderator variables  
Tables 2 and 3 display the results of the ANOVAs and meta-regressions, respectively, to examine the 
influence of qualitative and continuous moderator variables on the effect sizes.  
As Table 2 shows, none of the qualitative moderators exhibited a statistically significant relationship 
with the effect sizes. Only the clinical status approached statistical significance on the effect sizes for 
DBP (P = 0.060, R2 = 0.17), with the normotensive samples presenting a better benefit, and 
statistically significant, from IRT (D+ =  -3.59mmHg) than the hypertensive ones (D+ =  -1.15mmHg), 
the last not reaching statistical significance. Furthermore, the intra-group analyses of the different 
categories belonging to each moderator variable showed statistically significant (P<0.05) and 
clinically relevant (with a probability >70%) positive effects on SBP, DBP (with the exception of the 
categories female, hypertensive and unilateral belonging to the sex, clinical status and type of 
 Figure 2 Forest plot systolic blood pressure. 
 
 
Figure 3 Forest plot diastolic blood pressure. 
 
 Figure 4 Forest plot mean arterial pressure. 
 
 
Figure 5 Forest plot heart rate. 
 
exercise moderator variables, respectively) and MAP (with the exception of the categories female 
and mixed and unilateral belonging to the sex and type of exercise moderator variables, 
respectively) outcomes. However, and for the heart rate, the intra-group analyses showed no 
significant main effects for any category of the moderator variables.  
With regards to the continuous moderators (Table 3), no statistically significant relationships were 
found for SBP, DBP and MAP effect sizes. For heart rate effect sizes, the PEDro score showed a 
positive, statistically significant relationship (P = 0.003; R2 = 0.34), with the larger PEDro scores being 
associated to the lower effect sizes. In addition, the percentage of men in the sample presented a 
negative, statistically significant relationship with the effect sizes (P = 0.038; R2 = 0.14), with better 
effect sizes as the proportion of men decreased. The difference between the percentages of men in 
the IRT and control groups also exhibited a statistically significant relationship with the effect sizes (P 
= 0.003; R2 = 0.35), but this finding was due to the influence of an outlier that presented a very large 
percentage difference in comparison to those of the other studies (27.7% in the study by Gill et al. 
[44]). In fact, no statistical significance was found when this study was removed from the analysis (P 
= 0.541; R2 = 0.00). 
Publication bias  
Funnel plots with the trim-and-fill method for imputed missing values were constructed for SBP, 
DBP, MAP and heart rate (see Appendices 3, 4, 5 and 6). For SBP (SDC 3, 
http://links.lww.com/HJH/B50), five effect sizes were imputed to symmetrize the funnel plot, 
leading to an average effect size D+ = -5.23mmHg (95% CI -6.85 and -3.60), which was statistically  
significant but lower than the original mean effect (D+ = -6.00mmHg), this last one exhibiting an 
overestimation of about 14.7%. For DBP (SDC 4, http://links.lww.com/HJH/B50), seven effect sizes 
were imputed to symmetrize the funnel plot, obtaining an average effect size statistically significant 
(D+ = -1.64mmHg, 95% CI -2.57 and -0.71), and indicating that the original mean effect (D+ = -
2.75mmHg) overestimated the true effect by about 67.7%. For MAP (SDC 5, 
http://links.lww.com/HJH/B50), two effect sizes were imputed to symmetrize the funnel plot, 
leading to a statistically significant average effect size (D+ = -2.90mmHg, 95% CI -4.34 and -1.54), and 
implying that the original mean effect (D+ = -3.20mmHg) overestimated the true effect by 10.3%. For 
heart rate (SDC 6, http://links.lww.com/HJH/B50), three effect sizes were imputed to symmetrize 
the funnel plot, giving an average effect size (D+ = -0.08, 95% CI -1.04, 1.21), which was practically 
null and did not reach statistical significance. Table 4 summarizes the real effects of the IRT 
(including the magnitude-based inference analysis) on the primary outcomes.  
All statistical analyses were accomplished under a random-effects model, and the trim-and-fill 
method was also applied to each of them. 
 
Table 2 Results of the mixed-effects ANOVAs for the qualitative moderator variables on the effect sizes obtained from 
systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate measures 
Moderator variable N (k) D+ (95% CI) P value Intra-group inferencec ANOVA results 
SBPa 
Sex 
Male 165 (7) 5.64 (-8.39, -2.89) 0.000059 100/0/0 Most likely worthwhile 
differences 
QB (2) = 0.67, P = 0.714 
R2 = 0.01 
QW (16) = 59.99, P < 0.0001 Female 32 (2) -8.00 (-12.99, -3.01) 0.00169 100/0/0 Most likely worthwhile 
differences 
Mixed 263 (10) -5.98 (-8.54, -3.43) 0.0000044 100/0/0 Most likely worthwhile 
differences 
Clinical status 
Hypertensive 172 (7) -4.69 (-7.65, -1.73) 0.00187 99/1/0 Very likely worthwhile 
differences 
QB (1) = 0.55, P = 0.458 
R2 = 0.01 
QW (19) = 56.55, P < 0.0001 Normotensive 296 (13) -6.02 (-7.89, -4.15) <0.00000001 100/0/0 Most likely worthwhile 
differences 
Extremity 
Upper (handgrip) 259 (10) -6.58 (-9.08, -4.08) <0.00001 100/0/0 Most likely worthwhile 
differences 
QB (1) = 0.50, P = 0.480 
R2 = 0.00 
QW (19) = 78.20, P < 0.0001 Lower (leg press) 233 (11) -5.39 (-7.58, -3.20) <0.00001 100/0/0 Most likely worthwhile 
differences 
Type of exercise 
Unilateral 102 (5) -6.26 (-9.91, -2.61) 0.000262 100/0/0 Most likely worthwhile 
differences 
QB (1) = 0.03, P = 0.871 
R2 = 0.00 
QW (19) = 95.01, P < 0.0001 Bilateral 390 (16) -5.92 (-7.90, -3.94) 0.000000005 100/0/0 Most likely worthwhile 
differences 
Age 
<45 years 247 (12) -5.89 (-8.09, -3.69) 0.00000015 100/0/0 Most likely worthwhile 
differences 
QB (1) = 0.02, P = 0.892 
R2 = 0.00 
QW (19) = 76.98, P < 0.0001 ≥45 years 245 (9) -6.14 (-8.95, -3.32) 0.000018 100/0/0 Most likely worthwhile 
differences 
Weeks of intervention 
<8 weeks 167 (7) -4.45 (-7.56, -1.33) 0.0051 94/6/1 Likely worthwhile 
differences 
QB (1) = 1.76, P = 0.184 
R2 = 0.09 
QW (19) = 99.42, P < 0.0001 ≥8 weeks 325 (14) -7.10 (-9.48, -1.33) 0.000000005 100/0/0 Most likely worthwhile 
differences 
DBPa 
Sex 
Male 165 (7) -2.63 (-4.37, -0.89) 0.00308 76/24/0 Likely worthwhile 
differences 
QB (2) = 1.13, P = 0.568 
R2 = 0.00 
QW (16) = 70.17, P < 0.0001 Female 32 (2) -1.19 (-4.29, 1.91) 0.453 30/65/5 Possibly trivial differences 
Mixed 263 (10) -3.11 (-4.79, -1.42) 0.00031 90/10/0 Likely worthwhile 
differences 
Clinical status 
Hypertensive 172 (7) -1.15 (-3.20, 0.89) 0.268 1/79/20 Likely trivial differences QB (1) = 3.55, P = 0.060 
R2 = 0.17 
QW (18) = 112.09, P < 0.0001 
Normotensive 296 (13) -3.59 (-5.11, -2.08) 0.0000032 100/0/0 Most likely worthwhile 
differences 
Extremity 
Upper (handgrip) 259 (10) -2.83 (-4.71, -0.95) 0.0032 80/20/0 Likely worthwhile 
differences 
QB (1) = 0.005, P = 0.945 
R2 = 0.00 
QW (19) = 106.84, P < 0.0001 Lower (leg press) 233 (11) -2.91 (-4.43, -1.40)0 0.00017 88/12/0 Likely worthwhile 
differences 
Type of exercise 
Unilateral 102 (5) -2.06 (-4.77, 0.66) 0.136 52/48/0 Possibly worthwhile 
differences 
QB (1) = 0.41, P = 0.521 
R2 = 0.00 
QW (19) = 88.14, P < 0.0001 Bilateral 390 (16) -3.04 (-4.32, -1.76) 0.0000032 94/6/0 Likely worthwhile 
differences 
Age 
<45 years 247 (12) -3.70 (-5.34, -2.07) 0.0413 100/0/0 Most likely worthwhile 
differences 
QB (1) = 2.03, P = 0.154 
R2 = 0.01 
QW (19) = 119.64, P < 0.0001 ≥45 years 245 (9) -1.91 (-3.75, -0.07) 0.0000094 46/54/0 Possibly worthwhile 
differences 
Weeks of intervention 
<8 weeks 164 (7) -3.50 (-5.23, -1.77) 0.000072 93/7/0 Likely worthwhile 
differences 
QB (1) = 1.26, P = 0.934 
R2 = 0.00 
QW (10) = 77.39, P < 0.0001 ≥8 weeks 325 (14) -2.31 (-3.47, -1.15) 0.0001 70/30/0 Possibly worthwhile 
differences 
MAPa 
Sex 
Male 109 (6) -3.46 (-5.94, -0.99) 0.00596 84/16/0 Likely worthwhile 
differences 
QB (2) = 0.14, P = 0.934 
R2 = 0.00 
QW (10) = 77.39, P < 0.0001 Female 32 (2) -2.78 (-7.18, 1.62) 0.215 67/28/5 Possibly worthwhile 
differences 
Mixed 114 (5) -2.81 (-5.91, 0.29) 0.0767 71/28/1 Possibly worthwhile 
differences 
Clinical status 
Hypertensive 105 (5) -2.71 (-5.07, -0.36) 0.024 72/28/0 Possibly worthwhile 
differences 
QB (1) = 0.06, P = 0.811 
R2 = 0.00 
QW (12) = 43.78, P < 0.0001 Normotensive 199 (9) -3.06 (-4.59, -1.52) 0.000096 93/7/0 Likely worthwhile 
differences 
Extremity 
Upper (handgrip) 184 (7) -3.65 (-5.97, -1.33) 0.0021 93/7/0 Likely worthwhile 
differences 
QB (1) = 0.25, P = 0.617 
R2 = 0.00 
Lower (leg press) 144 (8) -2.89 (-4.73, -1.06) 0.0021 83/17/0 Likely worthwhile 
differences 
QW (13) = 80.25, P < 0.0001 
Type of exercise 
Unilateral 87 (4) -3.07 (-6.17, 0.03) 0.0524 75/25/0 Likely worthwhile 
differences 
QB (1) = 0.01, P = 0.922 
R2 = 0.00 
QW (13) = 91.15, P < 0.0001 Bilateral 241 (11) -3.25 (-4.98, -1.52) 0.00023 93/7/0 Likely worthwhile 
differences 
Age  
<45 years 199 (9) -3.07 (-4.73, -1.42) 0.000262 91/9/0 Likely worthwhile 
differences 
QB (1) = 0.02, P = 0.875 
R2 = 0.00 
QW (13) = 54.04, P < 0.0001 ≥45 years 129 (6) -3.30 (-5.61, -0.99) 0.0051 87/13/0 Likely worthwhile 
differences 
Weeks of intervention 
<8 weeks 134 (5) -2.65 (-5.18, -0.12) 0.05 70/30/0 Possibly worthwhile 
differences 
QB (1) = 0.30, P = 0.584 
R2 = 0.00 
QW (13) = 86.19, P < 0.0001 ≥8 weeks 194 (10) -3.54 (-5.46, -1.61) 0.00032 94/6/0 Likely worthwhile 
differences 
Heart rateb 
Sex 
Male 132 (5) -2.29 (-4.64, 0.07) 0.0574 0/99/1 Very likely trivial differences QB (2) = 4.11, P = 0.128 
R2 = 0.01 
QW (10) = 47.59, P < 0.0001 
Female 32 (2) 0.52 (-2.27, 3.31) 0.715 0/100/0 Most likely trivial 
differences 
Mixed 134 (6) 0.76 (-1.27, 2.79) 0.463 0/100/0 Most likely trivial 
differences 
Clinical status 
Hypertensive 125 (6) -1.24 (-3.42, 0.94) 0.267 0/100/0 Most likely trivial 
differences 
QB (1) = 0.10, P = 0.749 
R2 = 0.00 
QW (12) = 63.19, P < 0.0001 Normotensive 181 (8) -0.76 (-2.68, 1.16) 0.4413 0/100/0 Most likely trivial 
differences 
Extremity 
Upper (handgrip) 163 (8) -1.12 (-2.74, 0.50) 0.167 0/100/0 Most likely trivial 
differences 
QB (1) = 0.19, P = 0.659 
R2 = 0.00 
QW (13) = 72.09, P < 0.0001 Lower (leg press) 167 (7) -0.55 (-2.52, 1.42) 0.589 0/100/0 Most likely trivial 
differences 
Type of exercise 
Unilateral 102 (5) -1.11 (-3.15, 0.93) 0.285 0/100/0 Most likely trivial 
differences 
QB (1) = 0.08, P = 0.773 
R2 = 0.00 
QW (13) = 70.02, P < 0.0001 Bilateral 228 (10) -0.73 (-2.26, 0.80) 0.347 0/100/0 Most likely trivial 
differences 
Age 
<45 years 181 (8) -0.67 (-2.39, 1.06) 0.448 0/100/ Most likely trivial 
differences 
QB (1) = 0.10, P = 0.750 
R2 = 0.00 
QW (13) = 69.53, P < 0.0001 ≥45 years 149 (7) -1.06 (-2.79, 0.66) 0.227 0/100/0 Most likely trivial 
differences 
Weeks of intervention 
<8 weeks 134 (5) -0.48 (-2.82, 1.85) 0.684 0/100/0 Most likely trivial 
differences 
QB (1) = 0.07, P = 0.796 
R2 = 0.00 
QW (13) = 71.60, P < 0.0001 ≥8 weeks 181 (10) -0.83 (-2.07, 0.41) 0.188 0/100/0 Most likely trivial 
differences 
N is the number of participants whereas the number in parentheses (k) represents the number of studies.  
95% CI, 95% confidence interval around D+; D+, average mean difference; DBP, diastolic blood pressure; MAP, mean arterial 
pressure; SBP, systolic blood pressure.  
aWorthwhile is an absolute change in BP of above 2mmHg for SBP, DBP and MAP.  
bFor heart rate, a worthwhile effect is a change above 5bpm.  
cIf chance of benefit and harm both are above 5%, true effect was assessed as unclear (could be beneficial or harmful). 
Otherwise, chances of benefit or harm were assessed as follows: below 1%, almost certainly not; 1–5%, very unlikely; above 
5–25%, unlikely; above 25–75%, possible; above 75–95%, likely; above 95–99%, very likely; above 99%, almost certain. 
 
 
 
Table 3 Results of the mixed-effects meta-regressions for the continuous moderator variables on the effect sizes obtained 
from systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate outcomes 
Predictor k bj SE QR P QE R2 
SBP 
PEDro score 21 -0.676 0.929 0.53 0.467 98.96* 0.00 
No. of weeks 21 -0.627 0.430 2.13 0.144 100.95* 0.00 
Intensity 19 -0.085 0.101 0.72 0.396 55.68* 0.00 
Age (mean) 21 -0.020 0.053 0.14 0.713 88.53* 0.00 
Age (difference) 21 -0.168 0.492 0.12 0.733 102.62* 0.00 
Sex (% male) 19 0.005 0.025 0.04 0.837 68.19* 0.00 
Sex (% difference) 19 0.017 0.094 0.03 0.856 93.95* 0.00 
DBP 
PEDro score 21 1.045 0.640 2.67 0.102 86.48* 0.02 
No. of weeks 21 0.042 0.235 0.03 0.857 108.24* 0.00 
Intensity 19 -0.051 0.081 0.39 0.530 117.91* 0.00 
Age (mean) 21 0.036 0.035 1.08 0.299 117.66* 0.00 
Age (difference) 21 0.343 0.267 1.65 0.199 82.54* 0.00 
Sex (% male) 19 -0.014 0.016 0.71 0.400 90.84* 0.00 
Sex (% difference) 19 0.017 0.053 0.11 0.743 112.71* 0.00 
MAP 
PEDro score 15 0.214 0.788 0.07 0.786 101.15* 0.00 
No. of weeks 15 -0.321 0.349 0.85 0.358 91.29* 0.00 
Intensity 13 -0.058 0.079 0.54 0.462 41.18* 0.00 
Age (mean) 15 -0.022 0.047 0.22 0.641 60.97* 0.00 
Age (difference) 15 -0.143 0.513 0.08 0.780 97.54* 0.00 
Sex (% male) 14 -0.011 0.021 0.28 0.597 82.31* 0.00 
Sex (% difference) 14 0.111 0.097 1.31 0.253 94.30* 0.00 
Heart rate 
PEDro score 15 1.934 0.643 9.05 0.003 55.72* 0.34 
No. of weeks 15 -0.346 0.271 1.63 0.201 66.97* 0.00 
Intensity 13 -0.022 0.083 0.07 0.794 62.18* 0.00 
Age (mean) 15 -0.025 0.035 0.50 0.480 67.44* 0.00 
Age (difference) 15 -0.363 0.316 1.33 0.250 72.22* 0.00 
Sex (% male) 13 -0.032 0.015 4.32 0.038 49.08* 0.14 
Sex (% difference) 13 0.208 0.070 8.83 0.003 33.38* 0.35 
Age (mean) = mean age (in years) of the experimental and control groups. Age (difference) = difference between the mean 
age of the experimental and control groups. Sex (% male) = mean percentage of men in the experimental and control 
groups. Sex (% difference) = difference between the percentage of men in the experimental and control groups. 
bj = regression coefficient for the predictor variable; DBP, diastolic blood pressure; k = number of studies; MAP, mean 
arterial pressure; QE = statistic for testing the model misspecification; QR = statistic for testing the statistical significance of 
the predictor variable; R2 = proportion of variance explained by the predictor variable; SBP, systolic blood pressure; SE = 
standard error of bj.  
*P<0.001. 
 
 
 
Table 4 Isometric resistance training effects (adjusted for publication bias) on the primary outcomes. 
Outcome D+ (95% CI) I2 Chances that the true effects were substantiala (%) 
Positive Trivial Negative Qualitative inferenceb 
SBP (mmHg) -5.23 (-6.85, -3.60) 80% 100 0 0 Most likely positive 
DBP (mmHg) -1.64 (-2.57, -0.71) 84% 23.4 76.6 0 Likely trivial 
MAP (mmHg) -2.9 (-4.34, -1.54) 86% 88.0 11.2 0 Likely positive 
Heart rate (BPM) 0.08 (-1.04, 1.21) 81% 0 100 0 Most likely trivial 
95% CI, 95% confidence interval for D+; CI, confidence interval around the mean effect size; D+, average mean difference; 
DBP, diastolic blood pressure; I2, heterogeneity index; k, number of studies; k, number of trials; MAP, mean arterial 
pressure; SBP, systolic blood pressure.  
aSubstantial is an absolute change in BP of above 2mmHg for SBP, DBP and MAP. For heart rate, a substantial effect is a 
change above 5bpm.  
bIf chance of benefit and harm both are above 5%, true effect was assessed as unclear (could be beneficial or harmful). 
Otherwise, chances of benefit or harm were assessed as follows: below 1%, almost certainly not; 1–5%, very unlikely; above 
5–25%, unlikely; above 25–75%, possible; above 75–95%, likely; above 95–99%, very likely; above 99%, most likely. 
 
DISCUSSION  
The primary findings of this systematic review and meta-analysis report that IRT elicits a sufficient 
stimulus in the cardiovascular function to reduce BP in adults. After having counteracted the 
influence of the publication bias (using the trim-and-fill method), statistically significant (P<0.05) and 
clinically relevant (>2mmHg) positive effects on the SBP [-5.23mmHg (95% CI -6.85 to -3.60)] and 
MAP [-2.9mmHg (95% CI -4.34 to -1.54)] outcomes has been shown after the application of an IRT 
programme. Although IRT produced a statistically significant reduction in DBP [-1.64mmHg (95% CI -
2.57 to -0.71)], the magnitude of the real effect found was not sufficient to exceed the threshold 
(>2mmHg) for being considered clinically relevant. These reductions in SBP and MAP, larger than 
2mmHg, disclosed relevant public health implications for the treatment of the HTA, so that the risk 
of coronary heart disease and stroke may be reduced up to 6 and 15% respectively [55,56]. Although 
the mechanisms responsible for these adaptations remain to be fully clarified, improvements in 
conduit and resistance vessel endothelium-dependent dilation, oxidative stress and autonomic 
regulation of heart rate and blood pressure have been reported [55]. Furthermore, IRT did not elicit 
any relevant effect on resting heart rate [-0.75bpm (95% CI -1.83 to 0.34)]. All of these results are 
based on 16 RCTs that involved 492 participants and with a mean quality score in the PEDro scale of 
5.9 (minimum 4, maximum 8). In the scientific literature, a number of randomized trials that analyse 
the effects of different IRT interventions on BP can be found. However, these randomized trials were 
excluded from the current systematic review and meta-analysis as they did not contain control 
groups. Only RCTs that compared the effects of one or more IRT intervention groups with those of a 
control group (non-intervention) were considered eligible as these studies are considered the most 
reliable evidence on the effectiveness of interventions because the risk of confounding factors 
influencing the results (true effects) is minimized or null.  
The robust methodology that has been used in the current meta-analysis to estimate the true effects 
of IRT on the main BP outcomes did not allow making direct comparisons with the results found in 
the previous meta-analyses conducted by Carlson et al. [13] and Inder et al. [14]. In this sense, 
Carlson et al. [13] and Inder et al. [14] did not apply random-effects models in some of their meta-
analyses (despite the fact that a moderate to large heterogeneity was identified) and the effect sizes 
reported were not adjusted for the possible influence of publication bias using quantitative 
methods. Leaving aside these methodological differences, in the present meta-analysis, the 
magnitude of the observed changes in the DBP and MAP outcomes after an IRT intervention was 
lower than those found in previous meta-analyses [13,14]. For example, for the DBP and MAP 
outcomes, Inder et al. [14] show an antihypertensive effect size of -3.91mmHg (95% CI -5.68 to          
-2.14) and -3.67mmHg (95% CI -4.84 to -2.48), respectively. However, the magnitude of the effects 
of IRT on SBP showed in the present meta-analysis were almost similar to those reported by Inder et 
al. [14] (-5.20; 95% CI -6.08 to -4.33) and lower than those reported by Carlson et al. [13] (-6.77; 95% 
CI -7.93 to -5.62). Therefore, the recently published studies have not only increased the statistical 
power on these analyses but have also reduced the effect sizes of IRT on the main BP outcomes. This 
decrease has been more substantial for the DBP outcome, and the updated effect of the IRT on DBP 
may not be clinically relevant and have limited public health implications. Similar to the present 
meta-analysis, neither Carlson et al. [13] nor Inder et al. [14] found clinically relevant IRT effects on 
resting heart rate. Whereas, the effect size found in our meta-analysis for the IRT on SBP is 
comparable or superior to the ones reported in previous meta-analyses for the aerobic training 
[6,9,57] and DRT [6,7]. Although the reductions in DBP and MAP elicited by the IRT were smaller 
than those seen in SBP, the effect sizes are at least comparable with changes observed from the 
aerobic training and DRT [6,9,57], and DRT [6,7] previously published meta-analysis.  
These positive effects of IRT for lowering BP along with the absence of documented side effects, the 
relative inexpensive and portable equipment needed (e.g. handgrip device) allowing exercise to be 
performed anywhere, the short duration of the training sessions (each IRT session last 8–12 min 
approximately) and its low level of cardiovascular stress elicited may lead IRT to become an 
appropriate nonpharmacological treatment for the prevention and treatment of HTA. These factors 
are especially true for patients who have no/limited access to a fitness centre, suitable equipment 
and/or supervision by a certified healthcare professional. Further, it aids those who are unable (for 
any reason) to reach the current exercise recommendations for blood pressure management in 
adults, that is, aerobic training of at least 150-min moderate intensity, 75-min vigorous intensity or 
an equivalent combination of both each week, and also at least 2 days of muscle strengthening [58]. 
However, it should be noted that for those persons who present associated comorbidities (i.e. 
obesity, diabetes) and who can be involved in a progressive aerobic training and DRT programme, 
the IRT should be considered as an adjunct, not an alternative, due to the additional effects that 
aerobic training and DRT have on body composition and glucose regulation, and also on the 
cardiovascular and musculoskeletal functions [5,59–61].  
The ANOVA findings examining the influence of qualitative moderator variables (i.e. clinical status, 
sex, extremity used for carrying out the exercises and type of exercise, age and weeks of 
intervention) on the effect sizes, inform that only the moderator ‘clinical status’ approached a level 
of significant difference (in favour of the normotensive category) on the effect size for the DBP 
outcome (P = 0.060, R2 = 0.17). Consequently, these findings support the use of IRT, irrespective of 
the sex and age, not only as non-pharmacology therapy for the treatment of the HTA but also as a 
preventive measure for those adults described as normotensive. Furthermore, as the extremity 
variable used for carrying out the exercise and type of exercise appear not to play a role in IRT 
responsiveness, clinicians and healthcare professionals can include unilateral or bilateral handgrip or 
leg extension isometric contractions in their IRT programmes. These results are not in agreement 
with the findings obtained in the meta-analysis conducted by Inder et al. [14]. In this sense, Inder et 
al. [14] found larger IRT antihypertensive effects (>2mmHg) on MAP in hypertensive [-5.91mmHg 
(95% CI -7.94 to -3.87)] and male [-4.13mmHg (95% CI -5.08 to -3.18)]) participants in comparison 
with the normotensive [-3.01mmHg (95% CI -3.73 to -2.29)] and female [-2.29mmHg (95% CI -3.87 to 
-0.71)] participants. Likewise, Inder et al. [14] reported that the ITRs carried out unilaterally [              
-8.92mmHg (95% CI -11.22 to -6.61)] and using the upper extremity [-6.88mmHg (95% CI -8.31 to       
-5.46)] showed larger reductions in SBP in contrast with those IRTs carried out bilaterally [                   
-4.58mmHg (95% CI -5.52 to -3.63)] and using the lower extremity [-4.20mmHg (95% CI                        
-5.30 to -3.09)]. Perhaps the larger number of studies included in the present meta-analysis (16 RCTs 
vs. 11 RCTs) has allowed a more powerful sub-analysis, and this may explain these discrepancies. 
However, for the moderators’ sex and clinical status, it should be noted that only two (32 
participants) and seven (172 participants) cohorts of the nine (197 participants) and 20 (468 
participants) cohorts included in their respective subgroup analysis involved female and 
hypertensive patients, and therefore, these findings should be considered with caution. More 
research on the effect of IRT is definitively needed in female and hypertensive populations to make 
evidence-based recommendations.  
Finally, the meta-regressions of the continuous moderator variables revealed that only the variables 
PEDro score (P = 0.003; R2 = 0.34) and the percentage of men in the sample (P = 0.038; R2 = 0.14) 
showed a statistically significant relationship with the heart rate effect size. As stated before, the 
limited number of women recruited in the intervention studies in comparison with their counterpart 
men may explain these results.  
Therefore, the findings found in the present meta-analysis do not support the statement reported by 
Inder et al. [14] that there is an existence of a dose–response relationship, so that the greater the 
frequency of the IRT, the larger the antihypertensive effects are on BP. The lack of significant 
interactions between the moderator intensity and the effect sizes of the BP outcomes was expected 
because most of the studies selected (n = 11) performed isometric contractions at 30–35% maximal 
voluntary contraction (MVC). However, those studies that have used isometric contractions below 
30–35% MVC in their IRT programmes [40,42,50] seem to indicate, that for the leg extension 
exercise at least, an isometric contraction of 20% MVC is required to achieve clinically relevant 
reductions in BP outcomes, although isometric contractions at 30–35% might be preferable. If 
isometric contractions above 30– 35% MVC may produce larger reductions in BP remain unknown as 
no studies have used such intensities. 
Limitations  
A number of potential limitations of the present meta-analysis have to be considered. First, there 
are limitations inherent to the primary literature such as: participants are aware of their allocation to 
a control or intervention group in IRT studies; and several important scientific criteria have not 
always been observed (e.g. regular follow-up of the control subjects, assessment of adherence to 
the training programme, attention to changes in other lifestyle factors and lack of blinded or 
automated measurements). Second, the small number of studies conducted in female and 
hypertensive patients make it difficult to quantify any sex-related and clinical status-related 
differences regarding the hypertensive effect elicited for IRT on the main BP outcomes. Third, all of 
the selected studies assessed resting BP in laboratory or clinic settings using conventional methods. 
Although two meta-analyses [5,6] have shown that changes in net daytime ambulatory SBP and DBP 
in response to aerobic training were reduced to a similar extent as conventional assessment of 
resting BP, ambulatory monitoring has shown to be a better predictor of target end-organ damage 
[62], and also cardiovascular outcomes in treated patients with hypertension [63]. Furthermore, 
ambulatory BP measures might reflect the extent of BP reduction induced by IRT better because of a 
higher reproducibility over time and an absent or negligible ‘white-coat’ and placebo effect [64]. 
Finally, another limitation is the evidence of publication bias in some of our meta-analytic results, 
inviting us to be cautious in interpretation of the results and to take the effect estimates obtained 
with the trim-and-fill method as more appropriate.  
In conclusion, isometric resistance training elicits a sufficient stimulus in the cardiovascular function 
to reduce BP in adults. In this sense, IRT has shown statistically significant (P<0.05) and clinically 
relevant (>2mmHg) positive effects on the SBP [-5.23mmHg (95% CI -6.85 to -3.60)] and MAP [-
2.9mmHg (95% CI -4.34 to -1.54)] outcomes. Although IRT also produces a statistically significant 
reduction in DBP [-1.64mmHg (95% CI -2.57 to -0.71)], the magnitude of the real effect found may 
not be enough to exceed the threshold for being considered clinically relevant. These hypertensive 
effects elicited by IRT on BP may be independent of the sex, age and clinical status of the patients. In 
addition, none of the IRT parameters coded (i.e. length of the programme, extremity used for 
carrying out the exercises, type of exercises, intensity) appear to have an impact on the different 
effect sizes calculated. Therefore, IRT may be considered to be a useful non-pharmacologic therapy 
for the prevention and management of HTA, especially for those patients who do not present 
associated comorbidities (i.e. obesity, diabetes), and do not have access to a fitness centre or 
suitable equipment and constant supervision by a certified healthcare professional; and/or are 
unable (for any reason) to reach the current exercise recommendations for blood pressure 
management in adults. 
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